IRulya Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IRLA and other ETFs, options, and stocks.

About IRLA

IRulya Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. 

CEO
Brigette Michelle Roberts
CEOBrigette Michelle Roberts
Employees
38
Employees38
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2012
Founded2012
Employees
38
Employees38

IRLA Key Statistics

Market cap
33.64M
Market cap33.64M
Price-Earnings ratio
-0.26
Price-Earnings ratio-0.26
Dividend yield
—
Dividend yield—
Average volume
108.88K
Average volume108.88K
High today
$33.08
High today$33.08
Low today
$27.40
Low today$27.40
Open price
$30.84
Open price$30.84
Volume
89.67K
Volume89.67K
52 Week high
$909.98
52 Week high$909.98
52 Week low
$4.99
52 Week low$4.99

Stock Snapshot

The current IRulya Therapeutics(IRLA) stock price is $33.08, with a market capitalization of 33.64M. The stock trades at a price-to-earnings (P/E) ratio of -0.26.

On 2026-10-23, IRulya Therapeutics(IRLA) stock moved within a range of $27.40 to $33.08. With shares now at $33.08, the stock is trading +20.8% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 89.67K, compared to an average daily volume of 108.88K.

Over the past 52 weeks, IRulya Therapeutics(IRLA) stock has traded between a high of $909.98 and a low of $4.99.

Over the past 52 weeks, IRulya Therapeutics(IRLA) stock has traded between a high of $909.98 and a low of $4.99.

IRLA News

Simply Wall St 7d
IRulya Therapeutics (Nasdaq:IRLA) - 株式分析 - Simply Wall Street

...

IRulya Therapeutics (Nasdaq:IRLA) - 株式分析 - Simply Wall Street

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own IRLA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.